Recent Updates
Recently added Catalysts
RVP Neutral Sentiment Score: 45/100

RETRACTABLE TECHNOLOGIES

Key Takeaway: Retractable Technologies, Inc. has announced a workforce reduction of approximately 22% due to decreased need for domestic production personnel. This decision is expected to save the company approximately $1.7 million annually, although it will incur separation costs of around $154 thousand. The company maintains that it will still meet its current domestic production needs and retain significant production capacity going forward.

Market Sentiment Analysis

POSITIVE FACTORS

  • Expected annual savings of approximately $1.7 million.
  • Company can still meet current domestic production needs.
  • Continued significant domestic production capacity.

CONCERNS & RISKS

  • Workforce reduction by approximately 22%.
  • Separation costs of approximately $154 thousand.
  • Potential challenges related to supply chain disruptions.

Full Press Release Details

RETRACTABLE TECHNOLOGIES, INC. ANNOUNCES WORKFORCE
LITTLE ELM, TX, March 27, 2023 - Retractable
Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 22%. The reduction is due to the decreased
need for domestic production and production support personnel. The staff reduction primarily affects the Company's production, operations,
and logistics departments. The reduction will result in an overall annualized savings of approximately $1.7 million, or 13% in annualized
payroll expense, offset by separation costs which are expected to be approximately $154 thousand. The Company expects that it will be
able to meet its current level of domestic production needs after the headcount reduction and will continue to have significant domestic
production capacity.
Retractable manufactures and markets VanishPoint
and Patient Safe safety medical products and the EasyPoint needle. The VanishPoint
syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle
directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are uniquely
designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable
needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint
needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general
more information on Retractable, visit its website at www.retractable.com.
Forward-looking statements in this press release
are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect Retractable's current
views with respect to future events. Retractable believes that the expectations reflected in such forward-looking statements are accurate.
However, Retractable cannot assure you that such expectations will materialize. Actual future performance could differ materially from
Factors that could cause or contribute to such
differences include, but are not limited to: supply chain disruptions, Retractable's ability to scale up production volumes in response
to an increase in demand, potential tariffs, Retractable's ability to maintain liquidity; Retractable's maintenance of patent protection;
Retractable's ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk;
Retractable's ability to access the market; production costs; the impact of larger market players in providing devices to the safety market;
and other risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities
and Exchange Commission.
Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President, Chief Financial Officer, and Chief

Frequently Asked Questions

Why did Retractable Technologies reduce its workforce?

Retractable Technologies reduced its workforce by about 22% due to decreased domestic production needs.

What departments were affected by the workforce reduction?

The staff reduction primarily impacted the production, operations, and logistics departments.

How much will the workforce reduction save the company annually?

The workforce reduction will save approximately $1.7 million annually in payroll expenses.

What products does Retractable Technologies manufacture?

Retractable manufactures VanishPoint, Patient Safe products, and the EasyPoint needle.

What is the purpose of the VanishPoint syringe?

The VanishPoint syringe is designed to prevent needlestick injuries by retracting the needle.

Last updated: Mar 27, 2023